Apoptosis, annexin A5 and anti-annexin A5 antibodies in the antiphospholipid syndrome [PDF]
Journal of Medical Biochemistry, 2013 It has been proposed that apoptosis is one of the mechanisms involved in the generation of antiphospholipid antibodies. The presence of antiphospholipid antibodies is the main laboratory criterion for a definite diagnosis of the antiphospholipid syndrome.
Bećarević Mirjana +2 more
doaj
Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study [PDF]
, 2013 We determined whether any individual cancers are increased or decreased in a cohort of 595 patients with systemic lupus erythematosus (SLE) followed for up to 32 years at the University College London Hospitals Lupus Clinic, looking for any associated ...
Dey, D, Isenberg, DA, Kenu, E
core +1 more source
AMAUROSIS FUGAX IN PRIMARY ANTIPHOSPHOLIPID SYNDROME: DATA FROM APS-RIO COHORT
, 2022 Adriana Miranda de Magalhães Franco +6 more
openalex +1 more source
Case report: Mitral valve replacement for Libman-Sacks endocarditis and cerebral embolism of primary antiphospholipid syndrome [PDF]
, 2022 Huili Liang, Chunyan Ma, Xin Chen
openalex +1 more source
Neonatal Antiphospholipid Syndrome
NeoReviews, 2014 Antiphospholipid antibody syndrome (APS) during pregnancy may result in pregnancy morbidity and passive transfer of antibodies to the fetus, resulting in an increased risk of prematurity, intrauterine growth restriction, thrombocytopenia, and developmental delay.
Magalhães, Claudia Saad +2 more
openaire +2 more sources
Pregnancy, Volume 2, Issue 2, March 2026.Abstract Prophylactic low‐dose aspirin is recommended to reduce the risk of preeclampsia in pregnant persons with risk factors. Sixteen distinct risk factors are recognized, including elements of current and past medical and obstetrical history, family history, and examination findings.
Society for Maternal‐Fetal Medicine (SMFM) +3 more
wiley +1 more source
ACR Open Rheumatology, Volume 8, Issue 2, February 2026.Objective Severalstudies have highlighted the role of Type I interferons (IFN‐I) in activating inflammatory pathways in lupus. However, no previous research focused on investigating the role of IFN‐I gene expression in the ophthalmologic involvement of systemic lupus erythematosus (SLE).
Raphael Teixeira Costa +6 more
wiley +1 more source
Immunomodulation in the Treatment of Refractory Catastrophic Antiphospholipid Syndrome
Case Reports in Hematology, 2018 Catastrophic antiphospholipid syndrome is a rare condition with high morbidity and mortality. We present a refractory case of catastrophic antiphospholipid syndrome with a view to highlight the importance of early identification and aggressive treatment ...
Karthik Nath, Andrew McCann
doaj +1 more source
A Case of Severe Pre‐Eclampsia Complicated by HELLP Syndrome and Extensive Hepatic Infarction
Clinical Case Reports, Volume 14, Issue 2, February 2026.ABSTRACT Extensive hepatic infarction is a rare but potentially fatal complication of HELLP syndrome and is often difficult to recognize because of nonspecific clinical manifestations. A 34‐year‐old woman developed HELLP syndrome shortly after cesarean delivery for severe pre‐eclampsia, presenting with oliguria, marked thrombocytopenia (50 × 109/L ...
Tiange Xia +3 more
wiley +1 more source
Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE [PDF]
, 2015 Introduction: The current mainstay of the treatment of thrombotic antiphospholipid syndrome (APS) is long-term anticoagulation with vitamin K antagonists (VKAs) such as warfarin. Non-VKA oral anticoagulants (NOACs), which include rivaroxaban, have been
Clawson, S +7 more
core +1 more source